Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neuropace Inc
(NQ:
NPCE
)
9.700
+0.700 (+7.78%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuropace Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 29, 2023
Via
Benzinga
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
August 29, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 25, 2023
Via
Benzinga
NeuroPace to Participate in Upcoming Investor Conferences
August 24, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace's Return On Capital Employed Overview
May 18, 2023
Via
Benzinga
Recap: NeuroPace Q1 Earnings
May 04, 2023
Via
Benzinga
Looking Into NeuroPace's Return On Capital Employed
March 08, 2023
Via
Benzinga
NeuroPace Earnings Preview
March 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
August 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via
Benzinga
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
August 08, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
July 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces CEO Transition
June 28, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
People Are Lining Up For Elon Musk's Neuralink Brain Implant — Here's How You Can Invest In Brain Technology Startups
June 14, 2023
Via
Benzinga
NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
May 24, 2023
To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace’s RNS System
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
May 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
April 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 03, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Dow Jumps Over 300 Points; S&P 500 Rises 1.5%
March 03, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Friday. The Dow traded up 1.03% to 33,343.73 while the NASDAQ rose 1.92% to 11,682.86. The S&P...
Via
Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 03, 2023
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 03, 2023
Via
Benzinga
Nasdaq Up 150 Points; Crude Oil Rises 1%
March 03, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Friday. The Dow traded up 0.59% to 33,197.08 while the NASDAQ rose 1.32% to 11,614.60. The S&P...
Via
Benzinga
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
March 02, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via
Benzinga
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 10, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
January 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 13, 2023
Via
Benzinga
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
January 09, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.